Wenzel, M., Hoeh, B., Siech, C., Koll, F., Humke, C., Groener, D., . . . Mandel, P. (2025). Lutetium-177 PSMA radioligand therapy in taxan-naive first- and second-line metastatic castration resistant prostate cancer after first-line ARPI therapy. European Journal of Nuclear Medicine & Molecular Imaging, 52(6), 2015-2023.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
Wenzel, Mike, et al. "Lutetium-177 PSMA Radioligand Therapy in Taxan-naive First- and Second-line Metastatic Castration Resistant Prostate Cancer After First-line ARPI Therapy."
European Journal of Nuclear Medicine & Molecular Imaging 52, no. 6 (2025): 2015-2023.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
Wenzel, Mike, et al. "Lutetium-177 PSMA Radioligand Therapy in Taxan-naive First- and Second-line Metastatic Castration Resistant Prostate Cancer After First-line ARPI Therapy."
European Journal of Nuclear Medicine & Molecular Imaging, vol. 52, no. 6, 2025, pp. 2015-2023.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.